Eton Pharmaceuticals, Inc.
ETON- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001710340
In the last 90 days, Eton Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 164 institutions reported holding it in 13F filings for Q2 2026, worth $722.6M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Eton Pharmaceuticals, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- −2 vs. Q1 2023
- Shares held
- 5.98M
- +137.6K (+2.4%) vs. Q1 2023
- Total value
- $20.9M
- −$1.62M (−7.2%) vs. Q1 2023
- New holders
- 4
- 10 more added
- Sold out
- 6
- 5 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ETON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 164 | $722.6M |
| Q1 2026 | 116 | $438.6M |
| Q4 2025 | 104 | $277.5M |
| Q3 2025 | 103 | $394.7M |
| Q2 2025 | 87 | $243.3M |
| Q1 2025 | 86 | $189.7M |
| Q4 2024 | 71 | $181.5M |
| Q3 2024 | 48 | $60.0M |
| Q2 2024 | 45 | $28.7M |
| Q1 2024 | 44 | $28.8M |
| Q4 2023 | 56 | $33.5M |
| Q3 2023 | 50 | $28.8M |
| Q2 2023 | 33 | $20.9M |
| Q1 2023 | 35 | $22.5M |
| Q4 2022 | 31 | $18.2M |
| Q3 2022 | 32 | $14.4M |
| Q2 2022 | 29 | $14.6M |
| Q1 2022 | 31 | $27.4M |
| Q4 2021 | 32 | $24.1M |
| Q3 2021 | 37 | $29.5M |
| Q2 2021 | 46 | $48.1M |
| Q1 2021 | 50 | $63.7M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Eton Pharmaceuticals, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Opaleye Management Inc. | 2,285,000 | $7.97M | 1.91% | +100,000+4.6% | Added |
| Vanguard Group Inc | 976,436 | $3.41M | 0.00% | −3,847−0.4% | Reduced |
| Westside Investment Management, Inc. | 519,251 | $1.81M | 0.51% | +1,950+0.4% | Added |
| Acuitas Investments, LLC | 510,054 | $1.78M | 1.04% | +41,367+8.8% | Added |
| Paradigm Capital Management Inc | 300,000 | $1.05M | 0.06% | 00.0% | Unchanged |
| BlackRock Inc. | 298,225 | $1.04M | 0.00% | +5,560+1.9% | Added |
| Bridgeway Capital Management, LLC | 241,462 | $842.7K | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 210,092 | $733.2K | 0.00% | +23,510+12.6% | Added |
| AWM Investment Company, Inc. | 158,676 | $553.8K | 0.08% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 79,402 | $277.1K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 71,003 | $247.8K | 0.00% | 00.0% | Unchanged |
| Essex Investment Management Co LLC | 66,921 | $233.6K | 0.03% | +66,921 | New |
| Stratos Wealth Partners, LTD. | 58,025 | $202.5K | 0.00% | −34,285−37.1% | Reduced |
| Blair William & Co | 36,979 | $129.1K | 0.00% | +1,979+5.7% | Added |
| Northern Trust Corp | 32,943 | $115.0K | 0.00% | −147−0.4% | Reduced |
| Renaissance Technologies LLC | 27,600 | $96.0K | 0.00% | +14,200+106.0% | Added |
| Chicago Trust Co NA | 16,700 | $58.3K | 0.01% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 14,033 | $49.0K | 0.00% | +14,033 | New |
| Charles Schwab Investment Management Inc | 13,239 | $46.2K | 0.00% | 00.0% | Unchanged |
| Bailard, Inc. | 12,700 | $44.3K | 0.00% | +12,700 | New |
| Quantum Private Wealth, LLC | 11,500 | $40.1K | 0.02% | 00.0% | Unchanged |
| Raymond James & Associates | 10,000 | $34.9K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 5,911 | $20.6K | 0.00% | +5,911 | New |
| Citadel Advisors LLC | 5,822 | $20.3K | 0.00% | −6,087−51.1% | Reduced |
| Royal Bank of Canada | 4,881 | $17.0K | 0.00% | +4,511+1,219.2% | Added |
| Tower Research Capital LLC (TRC) | 4,374 | $15.3K | 0.00% | +973+28.6% | Added |
| Truvestments Capital LLC | 1,848 | $6.45K | 0.00% | 00.0% | Unchanged |
| Plante Moran Financial Advisors, LLC | 1,000 | $3.49K | 0.00% | 00.0% | Unchanged |
| NewSquare Capital LLC | 1,000 | $3.49K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 844 | $2.95K | 0.00% | −1,860−68.8% | Reduced |
| BNP Paribas Arbitrage, SA | 350 | $1.22K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 152 | $530 | 0.00% | +7+4.8% | Added |
| Lindbrook Capital, LLC | 4 | $14 | 0.00% | 00.0% | Unchanged |
| Lido Advisors, LLC | 0 | $0 | 0.00% | −44,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −17,380−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −16,200−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −15,889−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −10,964−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −5,387−100.0% | Sold out |